A study to characterise histological features of immune check-point inhibitor therapy-associated gastritis
Latest Information Update: 17 Dec 2020
At a glance
- Drugs Ipilimumab (Primary) ; Nivolumab (Primary) ; Pembrolizumab (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 17 Dec 2020 New trial record